Inventor · disambiguated record
Zhisen Zhang
Also filed as: ZHANG ZHISEN
13 granted patents·6 pending applications·47 citations·filing 2014–2024
88Inventor score
Files withHOFFMANN LA ROCHE19
Top patents by PatentIndex Score
19 records- 0193US9233978B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 12, 2016·18 cites·23 claims
- 0290US10081627B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 25, 2018·9 cites·30 claims
- 0389US10428069B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Oct 1, 2019·6 cites·21 claims
- 0483US9890167B2Pyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2016·Granted Feb 13, 2018·4 cites·50 claims
- 0580US9266904B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2014·Granted Feb 23, 2016·5 cites·23 claims
- 0679US9758530B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Sep 12, 2017·3 cites·14 claims
- 0775US11713327B2Heteroaryl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Aug 1, 2023·1 cites·17 claims
- 0874US12351575B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2019·Granted Jul 8, 2025·0 cites·13 claims
- 0974US10562905B2Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Feb 18, 2020·1 cites·6 claims
- 1066US2024360126A1Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1157US12421252B2Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·17 claims
- 1257US12421240B2Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 1357US2020181156A1Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1455US2024317735A1Hydroisoquinoline or hydronaphthyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1553US2023041743A11,8-naphthyridin-2-one compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1652US10683299B2Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Jun 16, 2020·0 cites·12 claims
- 1752US2021269451A1Pyridinyl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1850US11168086B2Methods of synthesizing pyrazine compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Nov 9, 2021·0 cites·20 claims
- 1948US2022340597A1Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →